01 January 2000
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene inmyocardial infarction survivors.
Jaroslav A. Hubacek, Jan Pitha, Ivana Podrapská, Jan Sochman, Vera Adámková, Vera Lánská, Rudolf PoledneMed Sci Monit 2000; 6(3): CR503-506 :: ID: 421318
Abstract
INTRODUCTION: Insertion/deletion (I/D) polymorphism of the angiotensin-convertingenzyme (ACE) gene influenced the plasma concentration of the ACE, and is D allele have been repetitivelysuggested as a risk factor for myocardial infarction (MI). MATERIAL AND METHODS: Two hundert thirty sixmale myocardial infarction survivors under 65 years and with body mass index and total plasma cholesterollevels under 95% of the Czech population were included in the study. As control group, 302 male controls(1% randomly selected group from the Czech population) were genotyped. I/D polymorphism in the ACE genewas determined using polymerase chain reaction. RESULTS: The prevalence of the I/I, I/D and D/D genotypeswas 0.218, 0.494 and 0.288, in the control group, and 0.178, 0.538 and 0.284, in the myocardial survivors,respectively. The male Czech population has the similar frequency of insertion and deletion alleles comparedto other Caucasian populations. The frequencies of the alleles and genotypes of the ACE gene did notdiffer significantly between MI survivors and a control sample of the Czech population. CONCLUSION: Itwas shown that the I/D polymorphism in the gene for ACE is not a genetic risk factor for myocardial infarctionin the Czech population.
Keywords: Blood Pressure, Body Mass Index, Cholesterol, Comparative Study, Czech Republic, DNA Transposable Elements, Gene Deletion, Genotype, Lipoproteins, HDL Cholesterol, Lipoproteins, LDL Cholesterol, Peptidyl-Dipeptidase A, Polymorphism, Genetic, Reference Values, Research Support, Non-U.S. Gov, Survivors, Triglycerides
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952